"目錄號: HY-14564A

Membrane Transporter/Ion ChannelNeuronal Signaling-

GTS-21二鹽酸鹽是一種選擇性α7煙堿型乙酰膽堿受體 (α7nAChR) 激動劑。

nAChR

相關產品

L-Nicotine-PNU-282987-Vinblastine-Carbamoylcholine chloride-PNU-120596-Pancuronium dibromide-Aniracetam-Catharanthine-Varenicline-Hexamethonium Bromide-Vecuronium bromide-Tebanicline hydrochloride-A-867744-Adiphenine hydrochloride-Cisatracurium besylate-

生物活性

Description

GTS-21 dihydrochloride is a selective α7 nicotinic acetylcholine receptor agonist, has recently been established as a promising treatment for inflammation. Target: nAChRin vitro: GTS-21 is one of the most potent α7nAChR agonists, has been reported to attenuate pro-inflammatory cytokine production, improve outcomes in sepsis models, pancreatitis, and ischemia-reperfusion injury, and inhibit the production of endotoxin-induced TNF in lung tissue. In addition, recent studies have demonstrated that GTS-21 inhibits the activities of endothelial cells and monocyte macrophages, as well as the secretion of pro-inflammatory cytokines in peripheral blood samples, by regulating the JAK2-STAT3 pathway. [1] in vivo: In septic animals, GTS-21 significantly ameliorated GI motility, lowered systemic and colonic levels of IL-6, decreased colonic permeability, and decreased the number of positive cultures obtained from blood and mesenteric lymph nodes. Splenectomy prevented animals from developing sepsis-induced ileus. Chrna7 mice displayed a more severe septic phenotype, whereas GTS-21 remarkably was also beneficial in these animals. [2]

Clinical Trial

NCT02538081

VA Office of Research and Development-University of Colorado, Denver

Schizophrenia

August 2015

Phase 1-Phase 2

NCT01400477

University of Colorado, Denver-National Institute of Mental Health (NIMH)

Schizophrenia-Schizoaffective Disorder

July 2011

Phase 2

NCT02458313

University of Colorado, Denver

Obesity

November 2015

Phase 1

NCT00414622

CoMentis

Alzheimer Disease

November 2006

Phase 2

NCT02111551

University of Colorado, Denver

Autism

June 2015

Phase 1

NCT00255918

University of Colorado, Denver-National Institute of Mental Health (NIMH)

Schizophrenia-Psychotic Disorders

March 2004

Phase 1

NCT00783068

Radboud University-CoMentis

Endotoxemia-Sepsis-Vagal Activity

August 2008

NCT02432066

University of Florida

Tobacco Use Disorder

June 29, 2017

Phase 2

View MoreCollapse

References

[1].Yue Y, et al. GTS-21 attenuates lipopolysaccharide-induced inflammatory cytokine production in vitro by modulating the Akt and NF-κB signaling pathway through the α7 nicotinic acetylcholine receptor. Int Immunopharmacol. 2015 Dec;29(2):504-12.

[2].Nullens S, et al. EFFECT OF GTS-21, AN ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST, ON CLP-INDUCED INFLAMMATORY, GASTROINTESTINAL MOTILITY, AND COLONIC PERMEABILITY CHANGES IN MICE. Shock. 2016 Apr;45(4):450-9.